Poland Pharma and Healthcare Sector Report 2025-2026

Poland's healthcare and pharmaceutical sector is dynamic and rapidly evolving, marked by innovation, resilience, and a growing global presence despite substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has placed considerable pressure on the Polish healthcare system. Nevertheless, strategic investments and modernization efforts are fostering positive developments. The healthcare and pharmaceutical retail sector is characterized by intense competition, with companies expanding their digital presence and retail networks. The sector continued to expand, driven by advancements in research and development (R&D), supportive government policies, and growing demand for innovative treatments. Leading firms such as Lux Med, Polpharma, and Adamed Pharma are heavily investing in R&D to introduce innovative products and enhance efficiency. Polpharma, a major Polish manufacturer, is focusing on R&D for generic and biosimilar medicines. Despite market competition and regulatory hurdles, Poland's pharma and healthcare sector is set for sustained growth, propelled by technological advancements and strategic initiatives.

This report provides a complete and detailed analysis of the "Pharmaceuticals production" sector for Poland. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the "Pharmaceuticals production" sector in Poland
• Crystallise the forces both driving and restraining this sector in Poland
• Ascertain Poland’s position in the global sector
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in Poland.
• Build a clear picture of trends, output and consumption for specific sub-sectors